Analyst Price Target is $14.00
▲ +164.15% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for Inogen in the last 3 months. The average price target is $14.00, with a high forecast of $26.00 and a low forecast of $8.00. The average price target represents a 164.15% upside from the last price of $5.30.
Current Consensus is
The current consensus among 4 polled investment analysts is to hold stock in Inogen. This Hold consensus rating has held steady for over two years.
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; and related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.